Cheapest GLP-1 Without Insurance Online (2026)

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetic variables that shape every metabolic decision. Browse all Peptides & GLP-1 education

If you typed "cheapest GLP-1 without insurance online" into a search bar, you are almost always in one of two situations: insurance refused to cover Wegovy or Zepbound, or the $1,000+/month retail sticker made branded GLP-1s feel impossible. Cash-pay is now a real market in 2026, and the headline numbers are scattered: Wegovy tablets list a $149/month starter price, Zepbound vials list $299/month for the 2.5 mg starting dose, and a long tail of telehealth platforms publishes compounded semaglutide and tirzepatide pricing anywhere from $119 first-month promos to $299/month standard. This guide walks the actual cost math, the medication-source split (compounded vs FDA-approved branded), the safety considerations on each side, and where the PlexusDx Microdose GLP-1 Protocol at $129/mo flat, Semaglutide Injection, and Tirzepatide Injection sit relative to the cheapest options on the market — because the right answer is rarely just the lowest number.

The cheapest GLP-1 without insurance in 2026 — quick frame

Three pricing structures cover the cash-pay GLP-1 market right now. FDA-approved branded medication direct from the manufacturer: Wegovy tablets at $149/month for the 1.5 mg and 4 mg starter tiers (4 mg listed at $149 through April 15, 2026, then $199), Wegovy pen at $199/month as a limited intro then $349/month, and Zepbound vials at $299/$399/$449/month depending on dose if you refill within 45 days. Compounded online programs: Tuyo Health at $155/mo, Breeze Meds from $199/mo, Eden Health from $119 first month, SkinnyRx from $199/mo, and MEDVi at $179 first month then $299/month. PlexusDx Weight Management Protocols: the Microdose GLP-1 Protocol at $129/mo flat is among the cheapest published cash-pay GLP-1 options anywhere online — below Wegovy tablets, below Tuyo, below Breeze, below MEDVi's ongoing rate, and well below Zepbound vials — with the optional Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) layered on top so dosing is anchored to your GLP1R, FTO, MC4R, and TCF7L2 variants instead of a population-average titration schedule. All of this is cash-pay; PlexusDx adds no membership fee and no contract.

The real annual math: what cash-pay GLP-1 actually costs in 2026

Monthly headlines are misleading; the question is what 12 months of GLP-1 therapy actually drains from your account. Wegovy tablets at $149/month for the 1.5 mg starter tier total roughly $1,788/year if you stay on the starter dose, but most patients titrate up — the 9 mg and 25 mg tiers list at $299/month, putting a maintained year closer to $3,588. Wegovy pen runs ~$2,388 if the $199 intro extends, then $349/month at $4,188/year on the standard rate. Zepbound vials run $3,588 at the 5 mg tier and up to $5,388/year at the 7.5–15 mg tiers if you stay inside the 45-day refill window — miss it and the regular tiers ($599–$1,049/month) push that toward $12,000/year. Compounded telehealth programs land between roughly $1,860 (Tuyo at $155/mo) and $3,468 (MEDVi standard). The PlexusDx Microdose GLP-1 Protocol at $129/mo flat lands at $1,548/year — the lowest 12-month total in this comparison — and includes async provider consultation, the prescription itself, the compounded medication, and shipping in one bill. Semaglutide Injection runs $2,148–$2,748/year ($179–$229/mo across five dose levels), Tirzepatide Injection runs $2,748–$3,708/year ($229–$309/mo across six dose levels), and GLP-Squared dual-compound runs $2,148–$3,900/year ($179–$325/mo). If insurance reliably covers Wegovy or Zepbound at a low copay, the branded route still wins on cost; if it doesn't — most commercial plans as of April 2026 — PlexusDx Microdose at $1,548/year is the cheapest published online GLP-1 path we have seen.

Why PlexusDx Microdose at $129/mo flat is among the cheapest GLP-1 options online

The $129/mo flat price on the Microdose GLP-1 Protocol is not a first-month promo, a prepay teaser, or a 3-month-bundle discount — it is a flat monthly rate, all-inclusive (async provider consult, prescription, compounded GLP-1 medication, and shipping bundled together, no membership fee). That structure matters because most under-$200 prices on competitor landing pages are first-month discounts that step up sharply at month two. At $129/mo flat — available in all 50 states, five of which require a scheduled live consult instead of async intake — Microdose comes in below Wegovy tablets' starter price ($149/mo), Tuyo Health ($155/mo), Breeze Meds ($199/mo), MEDVi's ongoing rate ($299/mo), and dramatically below Zepbound vials at any tier. Among compounded competitors: Tuyo $155/mo flat with quarterly labs, Breeze from $199/mo all 50 states, Eden $119 first month then variable, SkinnyRx from $199/mo, MEDVi $179 first month then $299/mo. The protocol uses compounded GLP-1 dispensed in four delivery formats — capsule, troche, lozenge, and sublingual — so patients who want to avoid weekly injections at the lowest published cash-pay price point have a route that matches search intent for "cheap GLP-1," "needle-free GLP-1," and "starter dose GLP-1" without trading off provider oversight. Patients who prefer injection have Semaglutide Injection at $179–$229/mo, Tirzepatide Injection at $229–$309/mo, or GLP-Squared dual-compound at $179–$325/mo on the same cash-pay structure.

FDA-approved vs compounded, plus safety basics

FDA-approved branded GLP-1 medications are Wegovy and Ozempic (semaglutide), Zepbound and Mounjaro (tirzepatide), Saxenda and Victoza (liraglutide), and Rybelsus (oral semaglutide tablets). These went through FDA premarket review and carry the approved label. Wegovy tablets, Wegovy pen, and Zepbound vials sold direct via NovoCare and LillyDirect are this category. Compounded semaglutide and tirzepatide — dispensed by Tuyo, Breeze, Eden, SkinnyRx, MEDVi, and PlexusDx — are prepared by licensed U.S. compounding pharmacies and are not FDA-approved as finished drug products. The FDA has documented dosing-error harms with compounded injectable semaglutide and warns specifically against salt forms (semaglutide sodium, semaglutide acetate) — different active ingredients than the base form used in approved drugs. PlexusDx uses licensed U.S. compounding pharmacies and dispenses the base form, not salt forms. On safety: all GLP-1 receptor agonists share a well-characterized side-effect profile (nausea, vomiting, diarrhea, constipation, abdominal pain, headache common; pancreatitis, gallbladder disease, acute kidney injury less common). The boxed warning for thyroid C-cell tumors applies to both semaglutide and tirzepatide based on rodent studies; both are contraindicated in patients with a personal or family history of medullary thyroid carcinoma or MEN-2. Cheap pricing is not a reason to skip oversight — verify that any program routes through a licensed clinician, dispenses through a state-licensed pharmacy, and ships cold-chain where required.

Why genetics matter when you are cost-shopping GLP-1

GLP-1 response varies meaningfully across patients. Variants in GLP1R (the GLP-1 receptor itself), GIPR (the GIP receptor relevant to tirzepatide), FTO (appetite regulation), MC4R (satiety signaling), and TCF7L2 (insulin response) are associated with measurably different response patterns to semaglutide and tirzepatide. The Precision Peptide Genetic Test maps 48 unique genes and 57 variants across 14 health pathways — including 34 weight-management insights and the GIPR rs1800437 variant linked to differential GLP-1 response — so the prescribing clinician knows whether a faster titration, a slower one, or a tirzepatide-first approach is more likely to fit your biology before week one. The test is $298 standalone or $99 as an add-on after your first month on any PlexusDx protocol. If you are pricing GLP-1 across providers, the math worth doing is: cheapest compounded protocol + $99 genetic add-on still beats the recurring price of most competitor programs in this comparison, and you walk in with a measurable baseline rather than a guess.

How to choose: a four-question decision frame for cheapest cash-pay GLP-1

Question 1: Does your insurance reliably cover Wegovy or Zepbound at a low copay? If yes, the branded pharmacy route is likely cheapest after copay. Question 2: Are you cash-pay with no GLP-1 coverage, and price is the dominant factor? Compare Wegovy tablets ($149/mo starter, $1,788/year if maintained) to the PlexusDx Microdose GLP-1 Protocol ($129/mo flat, $1,548/year all-inclusive). Question 3: Do you want the FDA-approved branded product specifically? Wegovy pen, Wegovy tablets, and Zepbound vials direct from the manufacturer are the cleanest regulatory route. Question 4: Do you want a genetic baseline informing dose and titration before the first dose? PlexusDx is the only option in this comparison that includes the Precision Peptide Genetic Test as part of the protocol pathway — standalone at $298 or $99 as an add-on after month one. The right answer is rarely just the lowest sticker price; it is the combination of monthly cost, medication source, oversight model, and whether your dose is anchored to your biology.

Frequently asked questions

What is the cheapest GLP-1 without insurance in 2026?

Among published cash-pay options, the PlexusDx Microdose GLP-1 Protocol at $129/mo flat is the lowest recurring price we have verified online. Wegovy tablets list $149/mo for starter tiers, Tuyo Health lists $155/mo, and Zepbound vials start at $299/mo for the 2.5 mg starting dose. Always confirm current pricing at checkout.

What is the cheapest GLP-1 option under $200/month?

PlexusDx Microdose at $129/mo flat, Wegovy tablets at $149/mo for the 1.5 mg starter tier, Tuyo Health at $155/mo, and Eden Health at $119 first month (ongoing varies). PlexusDx Microdose is the only one in that group that is a flat recurring rate and not a first-month promo or step-up offer.

Is compounded semaglutide the same as Wegovy or Ozempic?

No. Compounded semaglutide is prepared by a licensed compounding pharmacy and is not FDA-approved as a finished drug product; Wegovy and Ozempic are FDA-approved branded medications. The active ingredient is the same molecule, but the regulatory framework, premarket review, and post-market surveillance differ.

What should I avoid when shopping for cheap GLP-1 online?

Avoid sites that do not require a prescription, overseas sellers, impossibly low pricing, and any product described as semaglutide sodium or semaglutide acetate. The FDA states these salt forms are different active ingredients than the base form used in approved drugs and is not aware of any lawful basis for their use in compounding.

Does PlexusDx serve all 50 states and require membership?

Yes, PlexusDx Weight Management Protocols are available in all 50 states; five states require a scheduled live consult instead of async intake. There is no membership fee and no contract — pricing is flat-monthly cash-pay across all six protocols.

How does the $129/mo Microdose price compare to MEDVi, Tuyo, and Breeze?

PlexusDx Microdose at $129/mo flat is below MEDVi's $299/mo ongoing rate (after the $179 first-month promo), below Tuyo Health's $155/mo flat, and below Breeze Meds' $199/mo starting price. On a 12-month total it is the lowest published online cash-pay GLP-1 price in this comparison set.

Can genetics actually change which GLP-1 protocol is right for me?

Yes — variants in GLP1R, GIPR, FTO, MC4R, and TCF7L2 are associated with differential GLP-1 response. The Precision Peptide Genetic Test ($298 standalone or $99 as an add-on after your first month) gives the prescribing clinician a measurable baseline to anchor titration on before week one rather than starting from population averages.

Cheapest GLP-1 Without Insurance Online (2026): How PlexusDx Microdose at $129/mo Stacks Up | PlexusDx